SCTR supported investigators identify Sphingolipid fingerprint that predicts heart disease severity in African American lupus patients

Image
Image Credit
Licensed from http://www.scientificanimations.com, via the Creative Commons 4.0 license, available at https://creativecommons.org/licenses/by-sa/4.0/deed.en
Caption
3D still showing myocardial ischemia.

A team of MUSC researchers report in Frontiers in Immunology that they have identified a type of fat known as a sphingolipid that could predict the severity of heart disease in African American patients with lupus.

The team was led by Samar M. Hammad, Ph.D., associate professor in the MUSC College of Medicine, and the study was funded in part by a pilot project grant from the South Carolina Clinical & Translational Research Institute.

Publishing CTSA Program Hub’s Name
CTSA Program In Action Goals
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials